Literature DB >> 22879583

Visualization of vascular inflammation in the atherosclerotic mouse by ultrasmall superparamagnetic iron oxide vascular cell adhesion molecule-1-specific nanoparticles.

Marta Michalska1, Lina Machtoub, Helga D Manthey, Elisabeth Bauer, Volker Herold, Georg Krohne, Gunthard Lykowsky, Markus Hildenbrand, Thomas Kampf, Peter Jakob, Alma Zernecke, Wolfgang R Bauer.   

Abstract

OBJECTIVE: Noninvasive imaging of atherosclerosis remains challenging in clinical applications. Here, we applied noninvasive molecular imaging to detect vascular cell adhesion molecule-1 in early and advanced atherosclerotic lesions of apolipoprotein E-deficient mice. METHODS AND
RESULTS: Ultrasmall superparamagnetic iron oxide particles functionalized with (P03011) or without (P3007) vascular cell adhesion molecule-1-binding peptide were visualized by ultra high-field (17.6 T) magnetic resonance. Injection of P03011 resulted in a marked signal loss in the aortic root of apolipoprotein E-deficient mice fed a Western diet for 8 and 26 weeks in vivo and ex vivo, compared with preinjection measurements, P3007-injected mice, and P03011- or P3007-injected age-matched C57BL/6 controls. Histological analyses revealed iron accumulations in the intima, in colocalization with vascular cell adhesion molecule-1-expressing macrophages and endothelial cells. Coherent anti-Stokes Raman scattering microscopy demonstrated iron signals in the intima and media of the aortic root in the P03011-injected but not untreated apolipoprotein E-deficient mice, localized to macrophages, luminal endothelial-like cells, and medial regions containing smooth muscle cells. Electron microscopy confirmed iron particles enclosed in endothelial cells and in the vicinity of smooth muscle cells.
CONCLUSIONS: Using a combination of innovative imaging modalities, in this study, we demonstrate the feasibility of applying P03011 as a contrast agent for imaging of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22879583     DOI: 10.1161/ATVBAHA.112.255224

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  25 in total

Review 1.  Drug carrier interaction with blood: a critical aspect for high-efficient vascular-targeted drug delivery systems.

Authors:  Daniel J Sobczynski; Margaret B Fish; Catherine A Fromen; Mariana Carasco-Teja; Rhima M Coleman; Omolola Eniola-Adefeso
Journal:  Ther Deliv       Date:  2015-08-14

Review 2.  Vascular targeting of nanoparticles for molecular imaging of diseased endothelium.

Authors:  Prabhani U Atukorale; Gil Covarrubias; Lisa Bauer; Efstathios Karathanasis
Journal:  Adv Drug Deliv Rev       Date:  2016-09-15       Impact factor: 15.470

Review 3.  Targeting cell adhesion molecules with nanoparticles using in vivo and flow-based in vitro models of atherosclerosis.

Authors:  Khosrow Khodabandehlou; Jacqueline J Masehi-Lano; Christopher Poon; Jonathan Wang; Eun Ji Chung
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-01

Review 4.  Detection and treatment of atherosclerosis using nanoparticles.

Authors:  Jia Zhang; Yujiao Zu; Chathurika S Dhanasekara; Jun Li; Dayong Wu; Zhaoyang Fan; Shu Wang
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-05-31

Review 5.  Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation.

Authors:  Alexander Neuwelt; Navneet Sidhu; Chien-An A Hu; Gary Mlady; Steven C Eberhardt; Laurel O Sillerud
Journal:  AJR Am J Roentgenol       Date:  2015-03       Impact factor: 3.959

Review 6.  Molecular imaging of atherosclerosis with nanoparticle-based fluorinated MRI contrast agents.

Authors:  Rohun U Palekar; Andrew P Jallouk; Gregory M Lanza; Hua Pan; Samuel A Wickline
Journal:  Nanomedicine (Lond)       Date:  2015       Impact factor: 5.307

Review 7.  Targeting and therapeutic peptides in nanomedicine for atherosclerosis.

Authors:  Eun Ji Chung
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-27

8.  Endothelial Rap1 (Ras-Association Proximate 1) Restricts Inflammatory Signaling to Protect From the Progression of Atherosclerosis.

Authors:  Bandana Singh; Ramoji Kosuru; Sribalaji Lakshmikanthan; Mary G Sorci-Thomas; David X Zhang; Rodney Sparapani; Jeannette Vasquez-Vivar; Magdalena Chrzanowska
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-12-03       Impact factor: 8.311

Review 9.  Re-engineered imaging agent using biomimetic approaches.

Authors:  Tuyen Duong Thanh Nguyen; Ramesh Marasini; Santosh Aryal
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2021-10-26

Review 10.  Inflammatory signalings involved in airway and pulmonary diseases.

Authors:  I-Ta Lee; Chuen-Mao Yang
Journal:  Mediators Inflamm       Date:  2013-04-04       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.